Abstract
A novel class of Hsp90 inhibitors, structurally distinct from previously reported scaffolds, was developed from rational design and optimization of a compound library screen hit. These aminoquinazoline derivatives, represented by compound 15 (SNX-6833) or 1-(2-amino-4-methylquinazolin-7-yl)-3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one, selectively bind to Hsp90 and inhibit its cellular activities at concentrations as low as single digit nanomolar.
Copyright © 2012 Elsevier Ltd. All rights reserved.
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology
-
Cell Line, Tumor
-
Cell Proliferation
-
Drug Discovery
-
Drug Screening Assays, Antitumor
-
HSP90 Heat-Shock Proteins / antagonists & inhibitors*
-
HSP90 Heat-Shock Proteins / chemistry
-
Humans
-
Indoles / chemical synthesis*
-
Indoles / pharmacology
-
Models, Molecular
-
Protein Binding
-
Quinazolines / chemical synthesis*
-
Quinazolines / pharmacology
-
Small Molecule Libraries
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
HSP90 Heat-Shock Proteins
-
Indoles
-
Quinazolines
-
Small Molecule Libraries